Table 1 Baseline characteristics.
Total (N = 790) | AKI (N = 266) | No AKI (N = 524) | P | |
---|---|---|---|---|
Demographic | ||||
Age, year | 60.3 ± 17.1 | 62.4 ± 16.1 | 59.3 ± 17.6 | 0.012 |
Male gender, n (%) | 478 (60.5%) | 159 (59.8%) | 319 (60.9%) | 0.764 |
Medical history | ||||
CKD, n (%) | 59 (7.5%) | 39 (14.7%) | 20 (3.8%) | <0.001 |
DM, n (%) | 84 (10.6%) | 59 (22.2%) | 25 (4.8%) | <0.001 |
HTN, n (%) | 133 (16.8%) | 88 (33.1%) | 45 (8.6%) | <0.001 |
CVD, n (%) | 150 (19.0%) | 86 (32.3%) | 64 (12.2%) | <0.001 |
CLD, n (%) | 27 (3.4%) | 15 (5.6%) | 12 (2.3%) | 0.014 |
COPD, n (%) | 33 (4.2%) | 16 (6.0%) | 17 (3.2%) | 0.066 |
Asthma, n (%) | 32 (4.1%) | 18 (6.8%) | 14 (2.7%) | 0.006 |
AKI risk factors | ||||
Sepsis, n (%) | 283 (35.8%) | 111 (41.7%) | 172 (32.8%) | 0.014 |
Transfusion, n (%) | 360 (45.6%) | 148 (55.6%) | 212 (40.5%) | <0.001 |
Ventilator care, n (%) | 520 (65.8%) | 184 (69.2%) | 336 (64.1%) | 0.157 |
Medications | ||||
RAS blockers, n (%) | 76 (9.6%) | 53 (19.9%) | 23 (4.4%) | <0.001 |
CCB, n (%) | 59 (7.5%) | 38 (14.3%) | 21 (4.0%) | <0.001 |
Beta-blocker, n (%) | 64 (8.1%) | 45 (16.9%) | 19 (3.6%) | <0.001 |
Diuretics, n (%) | 68 (8.6%) | 45 (16.9%) | 23 (4.4%) | <0.001 |
Inotropics, n (%) | 543 (68.7%) | 207 (77.8%) | 336 (64.1%) | <0.001 |
Aminoglycoside, n (%) | 40 (5.1%) | 8 (3.0%) | 32 (6.1%) | 0.060 |
Vancomycin, n (%) | 114 (14.4%) | 41 (15.4%) | 73 (13.9%) | 0.575 |
Colistin, n (%) | 22 (2.8%) | 11 (4.1%) | 11 (2.1%) | 0.100 |
NSAID, n (%) | 436 (55.2%) | 134 (50.4%) | 302 (57.6%) | 0.053 |
Contrast, n (%) | 63 (8.0%) | 20 (7.5%) | 43 (8.2%) | 0.736 |
Chemotherapy, n (%) | 6 (0.8%) | 1 (0.4%) | 5 (1.0%) | 0.670 |
Laboratory findings* | ||||
PCT (ng/ml) | 0.3 (0.1, 3.6) | 0.7 (0.1, 7.1) | 0.2 (0.1, 2.7) | <0.001 |
Creatinine (mg/dl) | 1.1 (0.8, 1.4) | 1.3 (1.0, 2.1) | 1.0 (0.7, 1.2) | <0.001 |
hsCRP (mg/dl) | 1.6 (0.1, 11.1) | 2.5 (0.2, 14.3) | 1.3 (0.1, 9.5) | 0.005 |
WBC (103/mm3) | 12.7 (9.1, 18.0) | 13.1 (9.8, 18.5) | 12.5 (8.9, 17.8) | 0.116 |
pH | 7.3 (7.2, 7.4) | 7.3 (7.3, 7.4) | 7.4 (7.2, 7.4) | <0.001 |
pCO2 (mmHg) | 35 (28, 47) | 35 (27, 52) | 35 (29, 46) | 0.208 |
SpO2 (mmHg) | 70 (47, 101) | 68 (43, 95) | 72 (48, 103) | 0.153 |
Severity of illness* | ||||
SOFA score | 6.0 (4.0, 8.0) | 6.0 (4.0, 8.0) | 6.0 (4.0, 8.0) | 0.287 |